“Pharmacists Called to Take the Lead in Pharmacogenomics – the Bridge to Personalized Medicine”
– Pharmacy Today
Learn more about our partnerships with pharmacists
Genemarkers has a streamlined solution for incorporating PGX into pharmacy practice ideal for community pharmacists, long term care consulting pharmacists and pharmacy benefits managers who want to provide optimal medication management services.
Our Test Report offers the unique benefit of being thorough, yet easy to read. The report incorporates the most up-to-date clinical guidance from key scientific and government organizations including Clinical Pharmacogenetics Implementation Consortium (CPIC) and the Federal Drug Administration (FDA).
Clinically actionable information
Clear and concise reporting
Pharmacists & PGX in the news
Clinical implementation of personalized medicine in community pharmacies: considerations for clinicians
Personalized Medicine – The value proposition for management of medication use using pharmacogenomics (PGX) data to guide clinical decisions has been well documented. However, despite advances such as clinical guidelines developed by the Clinical Pharmacogenomics Implementation Consortium, hurdles remain to widespread integration of PGX into healthcare. […]
Pharmacy Today – Health care is inching closer to a reality in which patients are prescribed medications that work most effectively for them based on their DNA. The White House has been pulling resources together to make this happen since President Barack Obama announced the “Precision Medicine Initiative” during his State of the Union address in 2015. […]
American Pharmacist Association – In a case series published this September in JAMA, genetic testing in 91 children and young adults with refractory or relapsed cancer led to actionable findings that changed cancer treatment for almost one-half of the patients. Genetic testing to predict how a patient will respond to a given medication is improving patient safety and outcomes in numerous conditions. […]
American Pharmacist Association – In 2006, HHS initiated the Personalized Health Care Initiative with the goal of building the foundation for the delivery of gene-based care, which may prove to be more effective for large patient subpopulations. In the years since the initiative was launched, drug manufacturers and FDA have begun to incorporate pharmacogenomic data and applications of this information into the drug development, labeling, and approval processes. […]